BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4219)

  • 21. Serum tumor markers in metastatic breast cancer and course of disease.
    Caffier H; Brandau H
    Cancer Detect Prev; 1983; 6(4-5):451-7. PubMed ID: 6197167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholestasis and hepatic metastases: a factor contributing to extreme elevations of carcinoembryonic antigen.
    O'Brien MJ; Bronstein B; Zamcheck N; Saravis C; Burke B; Gottlieb LS
    J Natl Cancer Inst; 1980 Jun; 64(6):1291-4. PubMed ID: 6246298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of tumoral markers in serous effusions: carcinoembryonic antigen, alpha1-acidglycoprotein, alpha-fetoprotein, phosphohexose isomerase, and beta 2-microglobulin.
    Martinez-Vea A; Gatell JM; Segura F; Heiman C; Elena M; Ballesta AM; Mundo MR
    Cancer; 1982 Nov; 50(9):1783-8. PubMed ID: 6180821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer].
    Paulick R; Kaesemann H; Caffier H
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A comparison of serum phosphohexose isomerase and sialyl transferase activities in patients with malignant disease].
    Bayer PM; Ganzinger U; Burger EC; Gergely T; Gabl F; Moser K
    Wien Klin Wochenschr; 1977 Jan; 89(1):16-7. PubMed ID: 556872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
    Connell LC; Boucher TM; Chou JF; Capanu M; Maldonado S; Kemeny NE
    J Surg Oncol; 2017 Mar; 115(4):480-487. PubMed ID: 28008623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer.
    de Mello J; Struthers L; Turner R; Cooper EH; Giles GR
    Br J Cancer; 1983 Sep; 48(3):341-8. PubMed ID: 6688531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum levels of GPI, AAT and CEA in primary lung neoplasms and chronic bronchopneumopathies].
    Di Martino G; di Matteo L; De Bellis G; Iannucci F; Molero U; Catena E
    Boll Ist Sieroter Milan; 1979 Sep; 58(4):344-55. PubMed ID: 317940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R; Caffier H; Horner G; Lang K; Filbry E
    Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Carcinofetal antigens. II. Carcinoembryonic antigen (CEA). (author's transl)].
    Lamerz R; Fateh-Moghadam A
    Klin Wochenschr; 1975 Mar; 53(5):193-203. PubMed ID: 1080218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoembryonic antigen: clinical and historical aspects.
    Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
    Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Enzymatic changes in cancer].
    Iglesias J; GarcĂ­a-Villaescusa R; Ramos S; Silva MC; Veiras C
    Rev Esp Oncol; 1983; 30(4):567-76. PubMed ID: 6152858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases.
    Dong H; Tang J; Li LH; Ge J; Chen X; Ding J; Men HT; Luo WX; Du Y; Li C; Zhao F; Chen Y; Cheng K; Liu JY
    Asian Pac J Cancer Prev; 2013; 14(2):909-13. PubMed ID: 23621260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
    Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
    Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of biochemical tests to screen for metastases in patients with breast cancer.
    Coombes RC; Powles TJ; Gazet JC; Nash AG; Ford HT; McKinna A; Neville AM
    Lancet; 1980 Feb; 1(8163):296-7. PubMed ID: 6101748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of serum lactate dehydrogenase, phosphohexose isomerase, aldolase and hexokinase in prostatic carcinoma.
    Yeshowardhana
    Indian J Physiol Pharmacol; 1985; 29(1):33-8. PubMed ID: 2414222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The importance of measuring plasma carcinoembryonic antigen in small-cell anaplastic carcinoma].
    Michetti G; Bamberga M; Pugliese C; Ori Belometti M; Arnone P; Minio A; Ciaravino G; Villa R; Alesina R; Cottini M
    Minerva Med; 1994 May; 85(5):231-6. PubMed ID: 8028751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse.
    Lokich JJ; Zamcheck N; Lowenstein MW
    Ann Intern Med; 1978 Dec; 89(6):902-6. PubMed ID: 717986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.